LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000036 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,483
Total Value
$680,520.51
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 2,161 | $114.15 | $246,678.15 | 32,885 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 6, 2026 | Sale | 2,161 | $200.76 | $433,842.36 | 30,724 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Mar 6, 2026 | Exercise/Conversion | 2,161 | $0.00 | $0.00 | 0 | Direct | โ | View Details |